Anti-infection treatment for prostate inflammation

Anti-infection treatment of prostate disease I. The introduction of prostate disease is one of the common diseases in men ‘ s urology system, with more clinically infective prostate disease. Anti-infection treatment is a key component of the treatment of infectious prostate disease, and understanding of its treatment principles, drug choices and care is essential for effective treatment of prostate disease. II. Basic principle (i) of anti-infection treatment for prostate anemia states that pathogen screening methods should be as clear as possible before initiation of anti-infection treatment. Common screening methods include prostate fluid examination and bacterial training. The prostate gland fluid examination allows for the observation of indicators such as white cells, pyrophosphates, and preliminary determination of inflammation. Bacteria culture allows for the identification of specific pathogenic bacteria and for drug-sensitive testing to provide a basis for the precise choice of antibiotics. Special screening methods such as nucleic acid testing may also be required for specific pathogens, such as trachoma, chlamydia, and prostate inflammation caused by non-remunerative urea pathogens, such as decomposition. The choice of appropriate anti-infection drugs on the basis of the type of pathogens and the results of drug-sensitive tests is the basic principle of anti-infection treatment. Different pathogens are sensitive to different antibiotics, e.g. coli-Eshic is likely to be sensitive to quinone-like antibiotics, while gonorrhea is sensitive to antibiotics such as twilight. Thus, accurate pathogen diagnosis can help to improve treatment effectiveness and reduce drug resistance. (ii) The age, state of health and allergies of patients taking into account the patient ‘ s factors in individualized treatment need to be taken into account. For example, in the case of older patients, due to the possible decline in liver and kidney function, attention should be paid to the effects of dose and side effects on liver and kidney function in the choice of antibiotics. For patients with an allergy history of drugs, it is important to avoid the use of drugs that may cause allergy. The sexual status of patients may also affect treatment programmes. In the case of prostate inflammation caused by sexually transmitted diseases, the sexual partner of the patient also needs to be examined and treated at the same time in order to avoid cross-infection and lead to a recurrence of the disease. Treatment programmes vary according to the severity and type of prostate inflammation, which is classified as acute prostate and chronic prostate inflammation. Acute prostate inflammation is more severe and acute, usually requiring timely and effective anti-infection treatment and may require intravenous drugs to rapidly control inflammation. In the case of chronic prostate inflammation, which is relatively complex and has a long treatment cycle, there may be a need to combine other treatments, such as alpha-receptor retardants to improve urination symptoms, in addition to anti-infection treatment. III. Common anti-infection drug (i) Antibiotic quinone-type characteristics: Antibiotics of quinone have a wide spectrum of antibacterial and virulent properties. They can effectively suppress and destroy the bacteria common to prostate inflammation, such as coli-Eshi, transformation. The concentrations of such drugs in prostate tissues are relatively high and can be better antibacterial. Representing drugs and their use: Qenonone is a common drug, with a general intravenous drip dose of 0.5 – 0.75 g/s, or 1-2 times per day, for acute prostate disease, and an oral dose of 0.2 – 0.5 g/s, or 1-2 times per day, for chronic prostate disease, depending on the condition of the disease, which can be long, typically 2 – 4 weeks. Characteristics of head spasms: The antibacterial antibacterial activity of head bacterium is strong and has a better antibacterial effect on various bacteria. It is relatively safe and has relatively few side effects. The antibacterial spectrum varies from one generation to the next, and the appropriate replacements can be selected for the treatment of prostate disease on the basis of a possible fungus. On behalf of the drug and its use: Difoxin is a second-generation septactin, with oral doses of 0.25 – 0.5 g per day and 2 per day for precipititis caused by sensitive bacteria; for acute prostate infirmity, an intravenous drip can be used at a dose of 0.75 – 1.5 g per day and 3 per day. The gill is a third-generation cystasy, mainly for other antibiotics or suspected drug-resistant infections, with intravenous drip doses of 1 – 2 g/s, 2 – 3 times per day. Characteristics of the Great Cyclone: The Great Cyclone Antibiotics are mainly used to treat prostate inflammation caused by non-gonetic pathogens such as trachoma chlamydia, lysin. They can enter the cell and effectively inhibit the growth and reproduction of these pathogens. Representing drugs and their use: Achicillin is a commonly used substance of the Greater Circumpolar ester, with oral convenience, with a general first dose of 0.5 g, followed by 0.25 g per day for 5-7 days. For difficult cases, the treatment can be extended as appropriate. (ii) Other anti-infective combinations of sulfadoxine: Some antibacterial effect on common bacteria that cause prostate inflammation, such as coli-Eshicella, transformacicella, etc. It is relatively inexpensive and in some cases can be used as an empirical treatment option. Usage: Oral, 2 tablets per time (0.4 g per tablet with sulfamide and 0.08 g per tablet) 2 times a day. However, in the course of their use, care is taken to observe whether the patient has adverse reactions such as allergies, blood urine, etc. IV. The treatment process and care (i) The treatment of acute prostate inflammation in the treatment process generally requires rapid control of IVS, which can be converted to oral antibiotics after the symptoms have been mitigated. The total course of treatment is usually 2 – 4 weeks, which is determined on the basis of the patient ‘ s recovery and the results of bacterial training. During treatment, changes in the patient ‘ s symptoms, such as body temperature, pain, urination, etc., are closely observed. Chronic prostate inflammation treatment is relatively long, as chronic prostate inflammation is likely to persist. The course of antibiotics is usually 4-6 weeks or even longer. During treatment, prostate fluids need to be periodically reviewed to observe changes in indicators such as white cell numbers, ovose resin, etc., and to adjust the treatment programme to the improvement of the patient ‘ s symptoms. (ii) Different side effects of drug side effects monitoring for different anti-infective drugs. For example, quinone-type drugs may cause gastrointestinal reactions, such as nausea, vomiting, diarrhoea, and may also affect cartilage development, so children and pregnant women are generally not recommended for use. Pre-use is subject to a detailed examination of the history of allergies, with care to be taken to see if the patient suffers from allergies such as rashes, tickles and respiratory difficulties. In case of any discomfort during treatment, the patient should inform the doctor in time to adjust the treatment. Avoiding resistance to the use of antibiotics strictly in accordance with medical instructions, and avoiding self-inflicted dosage reduction or withdrawal. Irregular drug use can lead to bacterial resistance, making treatment more difficult. At the same time, in the course of the treatment, if there is a suspected drug-resistant infection, it should be tested in a timely manner to adjust the type of antibiotics. Joint treatment and combination therapy may require a combination of drugs for some complex cases of prostate inflammation. For example, the combined use of alpha-receptor retardants, while anti-inflammation treatments, can improve urination symptoms, and the joint use of inflammatory drugs can reduce pain and inflammation. In addition, physical therapy, such as prostate massage, hot water baths, microwave therapy, etc., can be combined to improve the effectiveness of treatment. In general, anti-infection treatment of prostate inflammation requires a combination of factors, the choice of appropriate drugs, and adherence to the correct treatment principles and protocols, with care to monitor drug side effects and avoid drug resistance to achieve good treatment.